ºÚÁÏÍø

Bile Acid Diarrhea (BAD) is a condition characterized by chronic diarrhea due to the excessive secretion of bile acids into the intestines. While it may not be as commonly recognized as other gastrointestinal disorders, BAD can significantly affect the quality of life for those affected. Bile acids, which are steroid acids produced in the liver from cholesterol, play a crucial role in digesting and absorbing dietary fats and fat-soluble vitamins. After being synthesized in the liver, bile acids are stored in the gallbladder and released into the small intestine during digestion. Most bile acids are reabsorbed in the ileum, the last part of the small intestine, and returned to the liver for reuse. Several underlying conditions can lead to bile acid diarrhea. One common cause is ileal resection or disease, where surgical removal of the ileum or diseases like Crohn’s disease impair bile acid reabsorption, resulting in excessive bile acids entering the colon.

Bile acid malabsorption can also occur due to genetic factors or intestinal diseases. Additionally, cholecystectomy, the surgical removal of the gallbladder, can alter bile acid dynamics, especially after consuming dietary fats, leading to increased secretion into the intestines. Certain medications, such as orlistat and some antibiotics, may contribute to BAD by affecting intestinal motility or bile acid metabolism. Functional disorders, including irritable bowel syndrome (IBS), can also manifest as bile acid diarrhea, complicating diagnosis and management. The primary symptom of bile acid diarrhea is chronic diarrhea, characterized by frequent, watery stools, an urgent need to defecate, and abdominal cramps or discomfort. Patients often experience a sense of incomplete evacuation after bowel movements, which can further exacerbate their discomfort and impact daily activities. Diagnosing BAD involves a combination of clinical evaluation and specific tests. A healthcare provider will start with a thorough medical history and physical examination, followed by stool tests to check for fat malabsorption and bile acid concentration. The SeHCAT test may also be utilized to measure bile acid retention in the body, with low retention indicating BAD. In some cases, additional imaging studies like CT or MRI might be necessary to identify structural abnormalities in the gastrointestinal tract. Management of bile acid diarrhea typically involves dietary modifications and pharmacological treatments. Adjusting dietary habits can alleviate symptoms; a low-fat diet is often recommended since bile acids are primarily involved in fat digestion. Reducing dietary fat can minimize bile acid secretion, while eating smaller, more frequent meals can help optimize digestion. Increasing soluble fiber intake, found in foods like oats and legumes, can bind bile acids in the intestines and improve stool consistency. Pharmacological treatments also play a significant role in managing BAD. Bile acid sequestrants, such as cholestyramine or colesevelam, bind bile acids in the intestine, reducing their secretion and alleviating diarrhea symptoms. While effective, these medications may cause side effects like constipation and bloating. In some cases, loperamide can help control diarrhea by slowing intestinal motility, although it should be used cautiously and not as a primary treatment. Probiotics may also offer benefits by restoring gut flora, although further research is needed to confirm their efficacy [1-4].

Regular follow-up with a healthcare provider is essential for monitoring symptoms, adjusting treatment plans, and effectively managing any underlying conditions. By recognizing the symptoms of bile acid diarrhea, understanding its potential causes, and pursuing appropriate management strategies, individuals can significantly improve their quality of life. If you or someone you know is experiencing chronic diarrhea, consulting a healthcare professional for proper evaluation and treatment is crucial. Early diagnosis and intervention can lead to better outcomes and a return to normalcy.

None.

None.

1. Sonnenberg A, Everhart JE (1996) . Am J Public Health. 86: 200–205.

   [] []

2. Julian RFW (2020) . Am J Gastroenterol. 115: 1974-1975.

   [] []

3. Julian RFW, Rafid S (2024) . Expert Rev Gastroenterol Hepatol. 18: 521-528.

   [] []

4. Camilleri M, Nurko S (2022) . Neurogastroenterol Motil. 34: e14287.

   [] []